OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...

Company to Highlight Broad Portfolio of Semiconductor and Passive Technologies in a Series of Reference Designs and Product ...

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving ...

Time named 58 U.S. health tech companies “outstanding” in its Sept. 18 listing of the top firms in the space globally for 2025. The publication partnered with market researcher Statista to rank health ...

Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

The MIT Technology Review has unveiled its annual "50 Smartest Companies" list, known as the TR50, with life sciences ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

The Triad has operations for two of the nation's top-10 employers for technology workers, according to the 2025 rankings from Forbes magazine.

These pioneers are aiming to do challenging and important medical work. One has already implanted 54 patients.

King of Prussia’s SEED Therapeutics pioneers “molecular glue” cancer drugs, with FDA approval for a rare pediatric trial.

The action aims to curb the overuse of the program, allowing companies to bring in only "highly skilled" workers from other ...